FDA.reportPublic FDA data

lamiVUDine 100 MG Oral Tablet

RxCUI
205328
RxNorm name
lamiVUDine 100 MG Oral Tablet
Display name
lamiVUDine 100 MG Oral Tablet
Full name
lamiVUDine 100 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LamivudineLAMIVUDINECamber Pharmaceuticals, Inc.6bd6b9da-df69-46db-813e-4e7f3bdecf952026-07-29Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 205328
LamivudineLAMIVUDINEGolden State Medical Supply, Inc.3c30216d-f9f5-104b-e063-6294a90af8fd2025-08-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 205328
LamivudineLAMIVUDINEApotex Corp.87095352-c088-74b1-7be0-d3e293a906112025-06-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 205328
lamivudineLAMIVUDINECamber Pharmaceuticals, Inc.e90671c6-7fff-48f4-8898-29f02d049c8b2025-01-09Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 205328

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
87095352-c088-74b1-7be0-d3e293a90611lamiVUDine 100 MG Oral TabletPSN11These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250617
87095352-c088-74b1-7be0-d3e293a906113TC 100 MG Oral TabletSY11These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250617
87095352-c088-74b1-7be0-d3e293a90611lamivudine 100 MG Oral TabletSCD11These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250617
6bd6b9da-df69-46db-813e-4e7f3bdecf95lamiVUDine 100 MG Oral TabletPSN5These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250109
6bd6b9da-df69-46db-813e-4e7f3bdecf953TC 100 MG Oral TabletSY5These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250109
6bd6b9da-df69-46db-813e-4e7f3bdecf95lamivudine 100 MG Oral TabletSCD5These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250109
e90671c6-7fff-48f4-8898-29f02d049c8b3TC 100 MG Oral TabletSY3These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250109
e90671c6-7fff-48f4-8898-29f02d049c8blamivudine 100 MG Oral TabletSCD3These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250109
e90671c6-7fff-48f4-8898-29f02d049c8blamiVUDine 100 MG Oral TabletPSN3These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250109
3c30216d-f9f5-104b-e063-6294a90af8fdlamiVUDine 100 MG Oral TabletPSN1LAMIVUDINE TABLETS (HBV). These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250812
3c30216d-f9f5-104b-e063-6294a90af8fd3TC 100 MG Oral TabletSY1LAMIVUDINE TABLETS (HBV). These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250812
3c30216d-f9f5-104b-e063-6294a90af8fdlamivudine 100 MG Oral TabletSCD1LAMIVUDINE TABLETS (HBV). These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV) for oral use Initial U.S. Approval: 199520250812
83009c27-f54b-47df-b8b2-e2e4e0b8f4e8lamivudine 100 MG Oral TabletSCD1These highlights do not include all the information needed to use EPIVIR-HBV safely and effectively. See full prescribing information for EPIVIR-HBV. EPIVIR-HBV (lamivudine) tablets for oral use EPIVIR-HBV (lamivudine) oral solution Initial U.S. Approval: 199520140303
83009c27-f54b-47df-b8b2-e2e4e0b8f4e8lamiVUDine 100 MG Oral TabletPSN1These highlights do not include all the information needed to use EPIVIR-HBV safely and effectively. See full prescribing information for EPIVIR-HBV. EPIVIR-HBV (lamivudine) tablets for oral use EPIVIR-HBV (lamivudine) oral solution Initial U.S. Approval: 199520140303
83009c27-f54b-47df-b8b2-e2e4e0b8f4e83TC 100 MG Oral TabletSY1These highlights do not include all the information needed to use EPIVIR-HBV safely and effectively. See full prescribing information for EPIVIR-HBV. EPIVIR-HBV (lamivudine) tablets for oral use EPIVIR-HBV (lamivudine) oral solution Initial U.S. Approval: 199520140303